Citation: Bkj. Wagner et Da. Ohara, PHARMACOKINETICS AND PHARMACODYNAMICS OF SEDATIVES AND ANALGESICS IN THE TREATMENT OF AGITATED CRITICALLY-ILL PATIENTS, Clinical pharmacokinetics, 33(6), 1997, pp. 426-453
Citation: Bkj. Wagner et Da. Ohara, PHARMACOECONOMIC ANALYSIS OF SEVOFLURANE VERSUS ISOFLURANE ANESTHESIAIN ELECTIVE AMBULATORY SURGERY, Pharmacotherapy, 17(5), 1997, pp. 1006-1010
Authors:
WAGNER BKJ
BERMAN SL
DEVITT PA
HALVORSEN MB
OHARA DA
Citation: Bkj. Wagner et al., A DOUBLE-BLIND, PLACEBO-CONTROLLED EVALUATION OF INTRANASAL METOCLOPRAMIDE IN THE PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING, Pharmacotherapy, 16(6), 1996, pp. 1063-1069
Citation: N. Zedie et al., COMPARISON OF INTRANASAL MIDAZOLAM AND SUFENTANIL PREMEDICATION IN PEDIATRIC OUTPATIENTS, Clinical pharmacology and therapeutics, 59(3), 1996, pp. 341-348
Authors:
WAGNER BKJ
AMORY DW
MAJCHER CM
DIFAZIO LT
SCOTT GE
SPOTNITZ AJ
Citation: Bkj. Wagner et al., EFFECTS OF INTRAVENOUS FAMOTIDINE ON GASTRIC-ACID SECRETION IN PATIENTS UNDERGOING CARDIAC-SURGERY, The Annals of pharmacotherapy, 29(4), 1995, pp. 349-353
Authors:
KORTIS HI
AMORY DW
WAGNER BKJ
WILSON E
LEVIN A
PITCHFORD DE
POLLAK P
Citation: Hi. Kortis et al., USE OF PATIENT-CONTROLLED ANALGESIA WITH ALFENTANIL FOR EXTRACORPOREAL SHOCK-WAVE LITHOTRIPSY, Journal of clinical anesthesia, 7(3), 1995, pp. 205-210
Authors:
WAGNER BKJ
DIFAZIO LT
AMORY DW
SCOTT GE
SPOTNITZ AJ
Citation: Bkj. Wagner et al., HEMODYNAMIC-EFFECTS OF INTRAVENOUS FAMOTIDINE IN PATIENTS UNDERGOING CARDIAC-SURGERY, Pharmacotherapy, 15(1), 1995, pp. 42-47
Citation: Bkj. Wagner et Da. Ohara, COST-ANALYSIS OF PROPOFOL VERSUS THIOPENTAL INDUCTION ANESTHESIA IN OUTPATIENT LAPAROSCOPIC GYNECOLOGIC SURGERY, Clinical therapeutics, 17(4), 1995, pp. 770-776
Citation: Bkj. Wagner et al., RETROSPECTIVE ANALYSIS OF POSTOPERATIVE NAUSEA AND VOMITING TO DETERMINE ANTIEMETIC ACTIVITY OF DROPERIDOL ADDED TO PROPOFOL - A POSSIBLE DRUG-INTERACTION, Pharmacotherapy, 14(5), 1994, pp. 586-591
Citation: Bkj. Wagner et Lf. Damelio, PHARMACOLOGICAL AND CLINICAL CONSIDERATIONS IN SELECTING CRYSTALLOID,COLLOIDAL, AND OXYGEN-CARRYING RESUSCITATION FLUIDS .2., Clinical pharmacy, 12(6), 1993, pp. 415-428
Citation: Bkj. Wagner et Lf. Damelio, PHARMACOLOGICAL AND CLINICAL CONSIDERATIONS IN SELECTING CRYSTALLOID,COLLOIDAL, AND OXYGEN-CARRYING RESUSCITATION FLUIDS .1., Clinical pharmacy, 12(5), 1993, pp. 335-346